Health
Study shows 90.7% efficacy for the BNT162b2 COVID vaccine in 5-11 year-olds – News-Medical.Net
A new study evaluates the safety, immunogenicity, and efficacy of the BNT162b2 in children who were 5 to 11 years of age.
Vaccination against coronavirus disease 2019 (COVID-19) has been considered to be the most effective way to reduce the mortality and morbidity of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Several vaccine candidates have…
Continue Reading
-
Noosa News20 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
-
Noosa News24 hours agoQueensland Cross-Border Commissioner and former police union boss Ian Leavers found dead at Brisbane home
-
Noosa News23 hours agoLogan man Umar Al Enizi cleared of murder after Browns Plains road rage incident in 2021
-
Noosa News20 hours agoDriver acquitted of murder over lengthy road-rage chase